Alkermes has developed this Billing Coding Guide for VIVITROL (naltrexone for extended-release injectable suspension) to assist physicians and other providers in understanding payer coverage, coding, and reimbursement for VIVITROL.
VIVITROL is an Anti-Addiction drug manufactured by Alkermes and administered via the Intramuscular route of administration. The J Code: J2315 is aligned to
HCPCS, CPT, or Revenue codes for drug Vivitrol and Injectable Naloxone
HCPCS (Level II) drug code on the claim. Medication Administration/Observation Service CPT code AND the J code J2315 Injection Naltrexone, 1mg (Vivitrol)
J3247: Permanent J-code for the IV formulation of COSENTYX Effective J, for all sites of care If COSENTYX is administered on or after J, the permanent J-code replaces the miscellaneous J-code J3590.
J Code/. Medication. Storage and Medication. Considerations. Appointment and To ease mixing, firmly tap the Vivitrol microspheres vial on a hard
If a claim is submitted with an unlisted J-Code (e.g. J3490) and there Vivitrol. J2315. OPIOD ANTAGONISTS. NO. Vpriv. J3385. ENZYME DISORDER - GAUCHERS
Vivitrol is a human prescription drug by Alkermes, Inc. The product is distributed in a single package with NDC code .
VIVITROL is billed using both the HCPCS code (J2315) and. NDC number ( ). Injection Services. Medicaid reimbursement for VIVITROL drug injection
R.